News Focus
News Focus
Followers 61
Posts 3673
Boards Moderated 0
Alias Born 01/27/2008

Re: Profit Pirate post# 186980

Monday, 11/01/2010 12:18:09 AM

Monday, November 01, 2010 12:18:09 AM

Post# of 192592
Actually there were close to 1.7 billion shares outstanding at the time of that offer, and prior to the buy-out offer even being publically mention it was found out that Jared had released an additional 300 million shares to max the A/S shares out at 2 billion. It appears his reasons for doing that was a lie as well. The buy-out offer was bogus/scam, just like all the other BS he feed to shareholders so his partners in crime could execute their wrap around agreements. IMO the only way he was able to make a buy-out offer of .10 per/share a believable story/scam to shareholders was because of the fake current sales and forward looking projection included in press reports like below. Just a little DD and you can see the whole buy-out fiasco was a con job.

FORT WAYNE, IN--(Marketwire - February 26, 2009) - Enzyme Environmental Solutions Inc. (PINKSHEETS: EESO) has set the stage for a breakthrough year by harvesting technology and vendors in medical, commercial/industrial and retail product formula lines.

"It's been a tremendous year and we're not even finished with first quarter. In addition to the recent coup secured with our exclusive retail partner, we've been underway on innovative solutions for medical and industrial sectors in addition to the successes we've had with Pit Solution and GC 2000 technologies," states Jared Hochstedler, CEO and President of the progressive green biotech company. "We have reviewed existing licensing agreements and product orders and have been conservative with received Letters of Intent and projected manufacturing orders and biotech licensing requests from several commercial vendors in sectors anywhere among the steel industry, medical fields and water treatment, among others and have estimated, moderately, projected gross sales are in excess of $136,000,000.00 ($136M) by end of 4th quarter, 2009. This does not include pending prospective contracts with Southeast Asia and the multitude of formula applications therein." Hochstedler continues, "We have worked diligently to secure alliances worldwide as part of an overall global strategy, introducing formulas and other biotechnology IP and took a risk in doing so; but it wasn't for a lack of vision. This was a large move I felt strongly about pursuing based on several vendor inquiries. The traditional model of simply getting products onto store shelves wasn't big enough for our overall mission: 'Cleaner world. Safer planet.'... It was an overall deliberate shift in market focus and distribution avenues on the retail side... and aggressively pursuing government agencies and entertaining solution requests from vendors internationally."

It's certainly paid off for EESO. The company recently released financials for Q3 and Q4 of 2008 on www.pinksheets.com and was upgraded to a 'limited information' company. EESO is currently in the process of fulfilling Pink OTC requirements toward 'current information' status as part of its promise to increase transparency and overall investor confidence as it paves the way for continued success and growth in the Green Biotech market internationally.

The company looks forward to sharing news of this forthcoming progress at tomorrow's Open House event at their Fort Wayne, Indiana offices.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y